These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 10229705)

  • 1. Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer.
    Hirvonen A
    Environ Health Perspect; 1999 Feb; 107 Suppl 1(Suppl 1):37-47. PubMed ID: 10229705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinations of susceptible genotypes and individual responses to toxicants.
    Hirvonen A
    Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):755-8. PubMed ID: 9255557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
    Ozawa S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
    Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
    Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility.
    Daly AK; Cholerton S; Armstrong M; Idle JR
    Environ Health Perspect; 1994 Nov; 102 Suppl 9(Suppl 9):55-61. PubMed ID: 7698086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
    Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
    Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity.
    Wormhoudt LW; Commandeur JN; Vermeulen NP
    Crit Rev Toxicol; 1999 Jan; 29(1):59-124. PubMed ID: 10066160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic polymorphisms in xenobiotic metabolizing enzymes as a determinant of susceptibility to environmental mutagens and carcinogens in humans].
    Ozawa S
    Yakugaku Zasshi; 1997 Nov; 117(10-11):895-909. PubMed ID: 9414599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of xenobiotics and chemical carcinogenesis.
    Lang M; Pelkonen O
    IARC Sci Publ; 1999; (148):13-22. PubMed ID: 10493245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response.
    Autrup H
    Mutat Res; 2000 Jan; 464(1):65-76. PubMed ID: 10633178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic and phenotypic polymorphisms in carcinogen-metabolizing enzymes and cancer susceptibility].
    Watanabe M
    Nihon Rinsho; 1996 Aug; 54(8):2261-75. PubMed ID: 8810806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer.
    Nebert DW; McKinnon RA; Puga A
    DNA Cell Biol; 1996 Apr; 15(4):273-80. PubMed ID: 8639263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility--a review.
    Raunio H; Husgafvel-Pursiainen K; Anttila S; Hietanen E; Hirvonen A; Pelkonen O
    Gene; 1995 Jun; 159(1):113-21. PubMed ID: 7607565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism of drug-metabolizing enzymes in relation to individual susceptibility to industrial chemicals.
    Nakajima T; Aoyama T
    Ind Health; 2000 Apr; 38(2):143-52. PubMed ID: 10812837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous genotyping of nine polymorphisms in xenobiotic-metabolizing enzymes by multiplex PCR amplification and single base extension.
    Knaapen AM; Ketelslegers HB; Gottschalk RW; Janssen RG; Paulussen AD; Smeets HJ; Godschalk RW; Van Schooten FJ; Kleinjans JC; Van Delft JH
    Clin Chem; 2004 Sep; 50(9):1664-8. PubMed ID: 15331501
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic polymorphisms and cancer susceptibility.
    Smith G; Stanley LA; Sim E; Strange RC; Wolf CR
    Cancer Surv; 1995; 25():27-65. PubMed ID: 8718512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular-epidemiological aspects of carcinogenesis: the role of xenobiotic metabolizing enzymes.
    Cascorbi I; Brockmöller J; Roots I
    Int J Clin Pharmacol Ther; 2002 Dec; 40(12):562-3. PubMed ID: 12503814
    [No Abstract]   [Full Text] [Related]  

  • 18. Do smoking and polymorphisms in xenobiotic metabolizing enzymes affect the histological stage and grade of bladder tumors?
    Ouerhani S; Rouissi K; Marrakchi R; Riadh Ben Slama M; Sfaxi M; Ayed M; Chebil M; Elgaaied A
    Bull Cancer; 2009 May; 96(5):E23-9. PubMed ID: 19467981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetic profile of xenobiotic enzyme metabolism in survivors of the Spanish toxic oil syndrome.
    Ladona MG; Izquierdo-Martinez M; Posada de la Paz MP; de la Torre R; Ampurdanés C; Segura J; Sanz EJ
    Environ Health Perspect; 2001 Apr; 109(4):369-75. PubMed ID: 11335185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.
    Kiss I; Németh A; Bogner B; Pajkos G; Orsós Z; Sándor J; Csejtey A; Faluhelyi Z; Rodler I; Ember I
    Anticancer Res; 2004; 24(6):3965-70. PubMed ID: 15736440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.